Zai Lab Officer Plans $212K Stock Sale Following Recent Insider Transactions

Form 144 Notice filed by Zai Lab officer Frazor T. Edmondson for the proposed sale of 5,877 American Depositary Shares with an aggregate market value of $212,344.83 on NASDAQ, planned for June 26, 2025.

Rhea-AI Filing Summary

Form 144 Notice filed by Zai Lab officer Frazor T. Edmondson for the proposed sale of 5,877 American Depositary Shares with an aggregate market value of $212,344.83 on NASDAQ, planned for June 26, 2025.

Key details of the transaction:

• Shares were acquired through restricted stock vesting on June 25, 2025 as compensation
• Sale is being executed through Fidelity Brokerage Services LLC
• Purpose includes covering tax obligations from vested equity award distribution

Recent trading history shows Edmondson sold 6,243 shares in April 2025 for total proceeds of $218,867.09. The filing confirms no knowledge of material adverse non-public information regarding Zai Lab's operations. Total shares outstanding: 486,853,250.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ZLAB shares is insider Frazor T. Edmondson selling on June 26, 2025?

According to the Form 144 filing, Frazor T. Edmondson plans to sell 5,877 American Depositary Shares of Zai Lab Limited (ZLAB) with an aggregate market value of $212,344.83 through Fidelity Brokerage Services LLC.

What was the reason for ZLAB insider Edmondson's share sale in June 2025?

The Form 144 filing indicates the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution. The shares were acquired through Restricted Stock Vesting on June 25, 2025 as part of compensation.

How many ZLAB shares did Frazor Edmondson sell in the past 3 months before this Form 144?

In the three months prior to this Form 144, Edmondson sold two batches of ZLAB shares: 4,369 shares on April 2, 2025 for gross proceeds of $156,821.76, and 1,874 shares on April 4, 2025 for gross proceeds of $62,045.33, totaling 6,243 shares.

What is ZLAB's total shares outstanding according to the June 2025 Form 144?

According to the Form 144 filing, Zai Lab Limited (ZLAB) had 486,853,250 shares outstanding at the time of the filing on June 28, 2025.

What position does Frazor T. Edmondson hold at ZLAB?

The Form 144 filing indicates that Frazor T. Edmondson III's relationship to the issuer (Zai Lab Ltd) is that of an Officer of the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2025 - 04:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001835780
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Zai Lab Ltd
SEC File Number	001-38205
Address of Issuer	4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI CHINA 201210
Phone	862161632588
Name of Person for Whose Account the Securities are To Be Sold	Edmondson Frazor Titus III
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5877	212344.83	486853250	06/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares	06/25/2025	Restricted Stock Vesting	Issuer			5877	06/25/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Frazor T. Edmondson 4560 Jinke Road Bldg. 1, 4th Floor, Pudong Shanghai F4 201210	American Depositary Shares	04/02/2025	4369	156821.76
Frazor T. Edmondson 4560 Jinke Road Bldg. 1, 4th Floor, Pudong Shanghai F4 201210	American Depositary Shares	04/04/2025	1874	62045.33

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	06/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Frazor T Edmondson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)